Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-11-01
1998-10-20
Davenport, Avis M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 21, 514 13, 514 14, 514 15, 530321, 530324, 530325, 530326, A61K 3800, A61K 3802, C07K 500, C07K 700
Patent
active
058246452
ABSTRACT:
A method of producing analgesia in nociceptive and neuropathic pain is disclosed. The method includes administering to a subject an omega conopeptide which is characterized by its ability to (a) inhibit electrically stimulated contraction of the guinea pig ileum, and (b) bind selectively to omega conopeptide MVIIA binding sites present in neuronal tissue. Also disclosed are novel omega conotoxin peptides effective in producing analgesia.
REFERENCES:
patent: 4975446 (1990-12-01), Trager et al.
patent: 5189020 (1993-02-01), Miljanich et al.
patent: 5587454 (1996-12-01), Justice et al.
Andersson, S.E. and Le Greves, P., "Ruthenium Red and Capsaicin Induce a Neurogenic Inflammatory Response in the Rabbit Eye: Effects of .omega.-conotoxin GVIA and tetrodotoxin," Eur. J. Pharmacol., 209:175-183 (1991).
Gohil Kishor Chandra
Justice Alan
Miljanich George P.
Singh Tejinder
Valentino Karen L.
Davenport Avis M.
Dehlinger Peter J.
Neurex Corporation
Stratford Carol A.
LandOfFree
Method of treating inflammation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating inflammation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating inflammation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-244327